Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. (Q46022616)
Jump to navigation
Jump to search
scientific article published on 10 June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. |
scientific article published on 10 June 2011 |
Statements
1 reference
Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. (English)
1 reference
Alex Morrison
1 reference
Xiaoyan Yan
1 reference
Chao Tong
1 reference
Ji Li
1 reference
10 June 2011
1 reference
301
1 reference
3
1 reference
H895-902
1 reference
Identifiers
1 reference
1 reference